$0.42
-0.02 (-4.59%)
Open$0.46
Previous Close$0.44
Day High$0.46
Day Low$0.42
52W High$2.54
52W Low$0.16
Volume—
Avg Volume3.45M
Market Cap106.39M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+8,182.9% upside
Current
$0.42
$0.42
Target
$34.78
$34.78
$27.07
$34.78 avg
$51.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.90M | 12.84M | 5.83M |
| Net Income | -437,345,340 | -510,718,575 | -1,267,217 |
| Profit Margin | -4,416.2% | -4,195.4% | -21.7% |
| EBITDA | -469,012,653 | -578,126,405 | -1,820,131 |
| Free Cash Flow | — | — | -1,133,887 |
| Rev Growth | -22.9% | -22.9% | +8.5% |
| Debt/Equity | 1.25 | 1.25 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |